Skip to main content

Table 4 Treatment Mode by Study Arm and Round (%)

From: Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial

  Correct Treatment Incorrect Treatment MDs asks patient preference (PP) (%) No prostate cancer treatment (NT) (%)
Overall Cont. Interv. Cont. Interv. Cont. Interv. Cont. Interv.
Round 1 17.9% 21.6% 22.4% 29.1% 25.5% 22.0% 34.2% 27.3%
Round 2 18.5% 29.1% 25.3% 21.1% 40.4% 32.7% 15.7% 17.1%
D in D estimation 6.9% −10.8% −4.3% 8.2%
p-value 0.001 0.028 0.210 0.021